GOSK clinical management protocol for vaginal cancer in Kenya - 2026
DOI:
https://doi.org/10.59692/xkf5ky53Keywords:
Kenya, Vaginal cancer, Vaginal neoplasmsAbstract
Objective: To develop a standardized, evidence-based clinical management protocol for vaginal cancer in Kenya through adaptation and contextualization of relevant international clinical practice guidelines.
Methods: The protocol was developed using a guideline adaptation approach to align recommendations from high-quality international clinical practice guidelines with Kenya’s healthcare system and resource context. A multidisciplinary development panel comprising gynecologic oncologists, pathologists, radiologists, oncology nurses, pharmacists, radiation oncologists, public health specialists, and patient representatives participated in the process. Panel members received technical training from the University of Nairobi and Kenyatta National Hospital on evidence-based guideline adaptation, including standardized appraisal, systematic evaluation of guidelines, and contextualization to local realities. A systematic search of PubMed and Google Scholar was conducted to identify relevant clinical practice guidelines and supporting evidence. Four guidelines were identified and independently appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Vaginal Cancer, the European Society of Gynaecological Oncology (ESGO) Guidelines for the Management of Patients with Vaginal Cancer, the Japan Society of Gynaecological Oncology (JSGO) Guidelines for the Treatment of Vulvar Cancer and Vaginal Cancer, and the Council for Medical Schemes, South Africa (CMS-SA) Final PMB Definition Guidelines for Vaginal and Vulvar Cancer were selected for analysis and adaptation, with the CMS-SA guideline adapted with modifications for the Kenyan context. The selected guidelines were systematically reviewed and their recommendations contextualized to Kenya’s healthcare and resource setting.
Results: The resulting protocol addresses the clinical evaluation and diagnosis, referral, histopathological assessment, staging, pre-treatment investigations, and management of vaginal cancer. It provides recommendations on the use of surgery, radiotherapy, chemotherapy, and systemic therapy according to disease stage and histological subtype. The protocol also addresses the management of recurrent and advanced disease, post-treatment surveillance, supportive and palliative care, and selected special clinical circumstances. It further supports multidisciplinary care, appropriate referral, participation in clinical trials, and consideration of emerging therapies where clinically appropriate and available.
Recommendations: The protocol provides standardized, evidence-based recommendations for the diagnosis, staging, treatment, surveillance, and management of recurrent vaginal cancer, adapted to the Kenyan healthcare and resource context. It is intended to support consistent clinical decision-making, multidisciplinary care, appropriate use of available resources, and equitable access to evidence-based cancer care across Kenya.
References
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
2. Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynecol Obstet. 2021;155(S1):19–27.
3. Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer. 2008;113(10 SUPPL.):2873–82.
4. Lombe DC, Mwamba M, Msadabwe S, Bond V, Simwinga M, Ssemata AS, et al. Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: A systematic review. BMJ Open. 2023;13(4):1–12.
5. Iyoke CA, Ugwu GO, Ezugwu EC, Ezugwu FO, Lawani OL, Onyebuchi AK. Challenges associated with the management of gynecological cancers in a tertiary hospital in South East Nigeria. Int J Womens Health. 2014;6(1):123–30.
6. European Society of Gynecological Oncology. vaginal cancer pocket guidelines [Internet]. Prague; Available from: https://www.esgo.org/media/2023/06/Pocket-Guidelines_Vaginal-cancer.pdf
7. Saito T, Tabata T, Ikushima H, Yanai H, Tashiro H, Niikura H, et al. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. Vol. 23, International Journal of Clinical Oncology. Springer Japan; 2018. 201–234 p.
8. Final PMB definition guidelines for ovarian cancer. Published date: 15 April 2019. Review due: 15 April 2021. 2019;(April 2019).
9. Donato V Di, Plotti F, Campus U, Roma B medico, Donato V Di, Bellati F, et al. Vaginal cancer Vaginal cancer. Crit Rev Oncol / Hematol [Internet]. 2011;81(May):286–95. Available from: http://dx.doi.org/10.1016/j.critrevonc.2011.04.004
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dr. Naomi N. Sitati, Prof. Rose J. Kosgei, Dr. Alfred Mokomba, Dr. Wycliffe Musalia, Dr. Millicent S. Masinde, Dr. Benjamin E. Odongo, Prof. Jacqueline J. Chesang', Dr. Victor T. Otieno, Dr. Francis O. Abinya, Dr. Yvonne N. Wekesa, Dr. Isaac M. Maingi, Dr. Bruce O. Semo, Dr. Margaret K. Kilonzo, Prof. Eunice J. Cheserem, Dr. Anwar Z. Mohamed, Dr. Stella N. Njenga, Dr. Diana Marion, Dr. Gideon M. Mutua, Dr. Simon M. Gitau, Dr. Steven M. Ibua, Dr. Innocent O. Maranga

This work is licensed under a Creative Commons Attribution 4.0 International License.
